Biovitrum, Symphogen manufacturing deal

Biovitrum (Stockholm, Sweden) will manufacture a rhesus D-specific recombinant polyclonal antibody for Symphogen (Copenhagen, Denmark). The antibody is in preclinical development to prevent hemolytic ...